hMOF的表达以及其对组蛋白H4K16乙酰基化酶活性在胃癌发病中的作用研究
[Abstract]:Histone acetyltransferases (HATs) and histone deathylation are important epigenetic regulatory mechanisms, including methylation, acetylation, ubiquitination, phosphorylation and glycosylation. Histone deacetyltransferases (HDACs) are co-regulated to maintain the dynamic balance of acetylation levels in cells. Therefore, any imbalance between acetylation and deacetylation caused by any cause will lead to abnormal cellular processes and even cancer. Recently, more and more research data show that all of them are complete. Acetylation of histone H4 at position 16 lysine K16 (H4K16) may be closely related to the development of some tumors. Acetylation of histone H4K16 in cells is regulated by a variety of histone modifying enzymes, while human acetyltransferase MOF (hMOF) participates in various cellular biological functions mainly through acetylation of H4K16. In order to further study and confirm the expression of hMOF and the acetylation level of histone H4K16 in stomach, we have found that the expression of hMOF may be associated with the development of some cancers, such as renal, ovarian and colon cancers. Correlation between cancers and whether the acetylation level of histone H4K16 in gastric cancer is regulated by other modified enzymes. In this study, we systematically investigated the expression of hMOF in gastric cancer tissues and cell lines by RT-qPCR, Western Blot, cell staining, overexpression and siRNA knockdown techniques. The acetylation level of whole cell histone H4K16 was correlated with the occurrence, clinical stage, pathological stage and prognosis of gastric cancer.
(1) The expression of hMOF gene was detected by RT-qPCR in 52 patients with gastric cancer. Statistical analysis showed that the expression of hMOF gene in 81% (42/52) of the cancer tissues was more than two times lower than that in normal tissues. Lymph node metastasis is associated with distant metastasis and is also associated with survival. However, there is no significant difference in the expression of hMOF gene between different age groups, sex groups and different cell differentiation groups.
(2) The expression level of HDAC4 gene was detected by RT-qPCR in 32 cases of gastric cancer, adjacent to cancer and normal tissues. Statistical analysis showed that the expression level of HDAC4 gene in gastric cancer increased, but there was no significant difference between them. There was no significant difference in metastasis, survival rate and distant metastasis of gastric cancer.
(3) The low expression of hMOF and high expression of HDAC4 were confirmed in two gastric cancer cell lines SGC-7901 and MGC-803 by RT-qPCR, WB and cell staining. The acetylation level of histone H4K16 was significantly lower in SGC-7901 and MGC-803 than in normal gastric mucosal cells GES-1. The results showed that the over-expression of hMOF increased the acetylation level of H4K16, but did not affect the mRNA and protein levels of HDAC4. On the contrary, siRNA knocked down HDAC4, which did not affect the protein surface of hMOF. Da did not increase the level of acetylation of H4K16 due to the decrease of deacetylation.
(4) Histone acetyltransferase hMOF is involved in the pathogenesis of gastric cancer. The acetylation level of H4K16 in gastric cancer cells is mainly regulated by hMOF acetyltransferase, not deacetylase HDAC 4.
【学位授予单位】:吉林大学
【学位级别】:博士
【学位授予年份】:2015
【分类号】:R735.2
【共引文献】
相关期刊论文 前10条
1 刘毅;张旋;魏涧;李虎宜;梁志恒;张栩亮;张有顺;;DNMT1、DNMT3b siRNA重组质粒的构建及鉴定[J];蚌埠医学院学报;2012年01期
2 姜树原;邵国;张胜;黄丽华;龚向峰;周立社;;人DNA甲基化转移酶3B1真核表达载体的构建和鉴定[J];包头医学院学报;2010年05期
3 刘斌;顾立萍;邢传平;苏勤军;高自芳;钱震;董亮;;胃癌组织中Dnmt1基因mRNA和蛋白的表达[J];第四军医大学学报;2009年20期
4 沈彦军;杨福合;杜卫华;朱化彬;郝海生;;哺乳动物体细胞核移植的DNA甲基化重编程研究进展[J];动物医学进展;2009年04期
5 ;Effect of antisense DNMT3b gene eukaryotic expression plasmid on expression of the DNMT3b gene in human biliary tract carcinoma cells[J];Hepatobiliary & Pancreatic Diseases International;2006年01期
6 石大伟;赵永成;;电离辐射诱导的DNA甲基化模式改变及其在辐射致癌机制研究中的意义[J];国际放射医学核医学杂志;2006年04期
7 左石;邹声泉;孙诚谊;;DNA甲基转移酶1基因在人肝外胆管癌组织和细胞中的表达及意义[J];贵阳医学院学报;2011年03期
8 左石;邹声泉;孙诚谊;;DNA甲基转移酶3b基因在肝外胆管癌组织中的表达[J];贵阳医学院学报;2011年04期
9 蒙丽娜;罗婷;柯浩;刘晓华;孙洪亮;陆凤花;石德顺;;DNA甲基转移酶抑制剂在动物体细胞核移植研究中的应用[J];中国畜牧兽医;2012年12期
10 李明;宋永胜;吴斌;卜仁戈;;DNA甲基化转移酶及DNA甲基化转移酶抑制剂在肿瘤研究中的新视角[J];癌症进展;2012年06期
相关会议论文 前2条
1 ;DNMT and Its Related Epigenetic Regulation in Lung Tumorigenesis[A];肿瘤病因学研究与中西医结合肿瘤综合诊疗交流研讨会论文集[C];2009年
2 陈菁菁;鲁显福;顾尔伟;;67.组蛋白去乙酰酶抑制剂应用于心血管疾病的研究进展[A];全国第四次麻醉药理学学术会议暨2013年贵州省麻醉学术年会论文汇编[C];2013年
相关博士学位论文 前10条
1 肖敏;急性髓系白血病的分子诊断研究[D];华中科技大学;2011年
2 马建霞;胰腺癌瘤体内放疗产生的DNA甲基化改变及诱发机体抗癌免疫反应的机制研究[D];第二军医大学;2011年
3 李月英;小G蛋白RhoA在肿瘤细胞核内的分布及其影响因素[D];江苏大学;2011年
4 苏中静;选择性转录起始位点和反义RNA调控人DHRS4基因簇的转录[D];汕头大学;2011年
5 林芸;PCOS患者子宫内膜INSR基因甲基化及DNA甲基化转移酶的研究[D];南方医科大学;2011年
6 崔宇;SCF~(FBXL15)复合体促进HECT类泛素连接酶Smurf1的降解及其在BMP信号通路中的功能研究[D];中国人民解放军军事医学科学院;2011年
7 黄磊;COX-2在大连地区胃癌中的低频率表达、甲基化状态及其肿瘤遗传学意义分析[D];大连医科大学;2006年
8 左石;胆管癌表遗传学研究[D];华中科技大学;2006年
9 刘国辉;错配修复基因、抑癌基因及微卫星不稳定性与乳腺癌相关性研究[D];吉林大学;2008年
10 张开立;高发区(大连)胃癌发病分子基础的探讨[D];大连医科大学;2008年
相关硕士学位论文 前10条
1 赵莹;四种抑癌基因p16、RASSF1A、CDH1、CDH13的甲基化状态及甲基转移酶活性和转录与肺癌的相关性研究[D];南京医科大学;2009年
2 杨蓓;干旱胁迫对节节麦DNA甲基化的影响[D];河南大学;2011年
3 李明;胃癌标本和正常胃组织中P53基因及其下游基因METTL9表达研究[D];山西医科大学;2011年
4 赵维敏;叶酸对宫颈癌细胞C33A和Caski中p16和DNMT1表达的作用[D];山西医科大学;2011年
5 方圆;水蛭提取物对肝癌HepG2细胞DNA甲基化转化酶的影响研究[D];湖南中医药大学;2011年
6 靳松;冠心病患者外周血中ER-α基因启动子区异常甲基化及其mRNA表达的研究[D];安徽医科大学;2011年
7 龙春兰;DNA甲基转移酶(DNMTs)在小鼠胚胎着床中的功能研究[D];重庆医科大学;2011年
8 郭良蕊;葡萄胎DNA甲基化研究[D];重庆医科大学;2011年
9 石元元;营养和空间因素对雌性蜜蜂发育的影响[D];江西农业大学;2011年
10 朱应超;CHFR基因CpG岛甲基化对Eca109细胞增殖凋亡的影响[D];山东大学;2011年
本文编号:2177903
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2177903.html